αααααβααΎαABUS β’ NASDAQ
add
Arbutus Biopharma Corp
4.15$
αααααααααα(0.24%)-0.010
4.14$
ααΆααα·αα 18 αα»ααΆ, 5:20:00 PM ααααβααα -4 · USD · NASDAQ · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·αααΆαααΈααααΆααααΆααααααΆααα
α’αΆαααα·α
αα·αααΈαα»α
4.12$
α
αααααααααααα
4.11$ - 4.19$
α
ααααααα½αααααΆαα
α»αααααα
1.69$ - 4.72$
ααΎαβαα»αβααΈααααΆα
783.45Β ααΆα USD
ααα ααα½αααΌαααααα
1.31Β ααΆα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
NASDAQ
ααααααΆαααΈααααΆα
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
(USD) | αα·αα»ααΆ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌα | 1.73Β ααΆα | -62.89% |
α
αααΆαααααα·ααααα·ααΆα | 21.98Β ααΆα | -3.15% |
α
αααΌααα»ααα | -19.80Β ααΆα | -15.81% |
ααααΆααα
αααααα»ααα | -1.15ααΆαα | -212.06% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | -0.15 | -14.22% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | -21.02Β ααΆα | -12.51% |
α’ααααΆαααααααααΆαααααα·αααααΆα | β | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
(USD) | αα·αα»ααΆ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 141.99Β ααΆα | -6.88% |
ααααααααα»α | 160.04Β ααΆα | -9.49% |
ααΆαααα½ααα»αααααΌαααα»α | 37.59Β ααΆα | -10.78% |
ααΌαβααααα»α | 122.45Β ααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 188.78Β ααΆα | β |
ααααααααααΉαααααα
| 6.34 | β |
ααα
ααααααΎαααααα | -34.43% | β |
ααα
ααααααΎααΎααα»α | -42.30% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
(USD) | αα·αα»ααΆ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌααα»ααα | -19.80Β ααΆα | -15.81% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | -14.50Β ααΆα | 25.84% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | 9.83Β ααΆα | 582.10% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | 24.37Β ααΆα | 413.92% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 19.69Β ααΆα | 247.17% |
ααα αΌαααΆα
αααααΆααααααα | -7.10Β ααΆα | 31.18% |
α’αααΈ
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
ααΆααααααΎαα‘αΎα
2007
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
73